Cas no 303-98-0 (coenzyme Q10)
coenzyme Q10 Chemical and Physical Properties
Names and Identifiers
-
- coenzyme Q10
- coenzyme Q10 synthetic
- ubidecarenone
- coenzyme Q-10
- Co Q10
- Coenzymen Q10
- Water-soluble Coenzymen Q10
- Hydrosoluble Coenzymen Q10
- QH 10
- Water-soluble QH10
- coenzyme q10 UBIDECARENONE
- COENZYME Q10(Natural)(P) PrintBack
- COENZYME Q10(Synthetic)(P)
- Q10 COENZYME
- Ubiquinone 10
- Carenone
- Coenz10
- CoenzyMe Q-199
- Coenzyme?Q10
- Coenzyme?Q10,Q-10,Ubiquinone 50
- eiquinon
- Ensorb
- Kudesan
- Liquid-Q
- neuqinon
- Q10
- Q-10
- Q-10 Ubiquinone 50 Ubiquinone-10
- Q-Gel
- Ubiquinone 50
- ubiquinone Q10
- Ubiquinone-10
- Ubiquinone-Q10
- Coenzyme Q10
- Ubiquinone
- Coenzyme Q10 reduced form
- CoQ10
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methyl-1,4-benzoquinone
- CoQ
- Q 199
- Adelir
- 2-((all-E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
- Q
- all-trans-ubiquinone
- 303-98-0
- Oristar ubq
- API 31510
- p-Benzoquinone, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-
- Q-Gel 100
- EX-A973
- GLXC-10860
- Kaneka Q10
- DB09270
- NS00014191
- CCRIS 9016
- Ube-Q
- 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-tetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methyl-[1,4]benzoquinone
- UBIDECARENONE (MART.)
- C1971
- Co-enzyme Q-10
- EN300-21680292
- C-7060
- vitamin Q10
- 2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-
- EINECS 206-147-9
- Tox21_113394
- Ubiquinone Q(sub 10)
- CAS-303-98-0
- Ubidecarenonum [Latin]
- Coenzymeq10,(S)
- CHEBI:46245
- 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
- MLS000028745
- UBIDECARENONE [WHO-DD]
- CoQ 10
- Ubidecarenone, United States Pharmacopeia (USP) Reference Standard
- Aqua Q10
- Ubidecarenone for system suitability, European Pharmacopoeia (EP) Reference Standard
- Aqua Q 10L10
- Q321285
- Armolipid
- Udekinon
- EJ27X76M46
- DTXSID6046054
- NCGC00159429-14
- 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all trans)-
- NSC 140865
- Tox21_111660
- UBIDECARENONE [MART.]
- unbiquinone
- UBIDECARENONE [USP-RS]
- coenzyme-Q10
- UBIDECARENONE FOR SYSTEM SUITABILITY (USP-RS)
- UBIDECARENONE [DSC]
- AC-4352
- NCGC00159429-13
- Neuquinone
- Ubidecarenone for system suitability
- Vitamin Q
- 2,3-dimethoxy-5-methyl-6-decaprenylbenzoquinone
- NCGC00159429-02
- C01EB09
- p-Benzoquinone,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-
- LMPR02010001
- UBIQUINONE 50 [MI]
- PureSorb Q 40
- NCGC00095322-03
- NSC140865
- BPM-31510
- Q 10
- Justquinon
- Ubidecarenonum
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
- Akvion
- Emitolon
- HY-N0111
- 2,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-
- 2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-
- DTXCID4026054
- Coenzyme Q10(CoQ10)
- KanekaQ10
- BP31510
- UBIDECARENONE [JAN]
- Unispheres Q 10
- 2-((all-E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione
- CO Q 10
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methylbenzo-1,4-quinone #
- LS-15517
- CoQ(sub 10)
- BRD-K75043328-001-03-4
- ubiquinone(10)
- Ubidecarenona
- 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone
- Ubidecarenone for System Suitability, United States Pharmacopeia (USP) Reference Standard
- Ubidecarenona [Spanish]
- NSC-140665
- 2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl
- CoQ10; Ubiquinone-10
- UBIDECARENONE [INN]
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
- BRD-K75043328-001-04-2
- SCHEMBL11901691
- (all-E)-2,3-dimethoxy-5-methyl-6-(3,7,11,15,19,23,27,31-octamethyl-2,6,10,14,18,22,26,30-dotriacontaoctaenyl)-2,5-Cyclohexadiene-1,4-dione
- AKOS015897104
- Heartcin
- COENZYME Q10 [VANDF]
- Coenzyme Q10, analytical standard
- CoenzymeQ10
- UBIDECARENONE FOR SYSTEM SUITABILITY [USP-RS]
- 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaenyl)-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione
- Ubiquinone-10 , CoQ10
- UBIDECARENONE (EP MONOGRAPH)
- 2-DECA(3-METHYLBUT-2-ENYLENE)-5,6-DIMETHOXY-3-METHYL-P-BENZOQUINONE
- Mitocor
- Coenzyme Q10, >=98% (HPLC)
- UBIDECARENONE [EP MONOGRAPH]
- Ubidecarenone [INN:BAN:JAN:NF]
- CS-0007796
- CHEMBL454801
- 2,5-Cyclohexadiene-1,4-dione, 2-((2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl)-5,6-dimethoxy-3-methyl-
- AKOS015951232
- Luvacor
- API-31510
- MFCD00042919
- UBIDECARENONE (USP-RS)
- Ubidecarenonum (Latin)
- Li-Q-Sorb
- Coenzyme Q(sub 10)
- BRD-K75043328-001-05-9
- Coenzyme Q
- CoQ10;Ubiquinone-10
- UNII-EJ27X76M46
- (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-Cyclohexadiene-1,4-dione
- D01065
- Terekol
- Co-Q10
- Coenzyme Q 10
- Bpm31510
- Adelir (TN)
- 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-p-benzoquinone, (all trans)-
- 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl]-5,6-dimethoxy-3-methyl- 2,5-Cyclohexadiene-1,4-dione
- Bio-Quinone Q10
- SMR000058651
- Bio-Quinon
- Ubidecarenone (JP17/INN)
- NSC-140865
- AS-13341
- 2,5-Cyclohexadiene-1,4-dione, 2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-, (all-E)-
- Neuquinon
- Ubidecarenone, European Pharmacopoeia (EP) Reference Standard
- CoQ10 200mg
- s2398
- Q 10AA
- SCHEMBL19858
- co-enzyme Q10
- Inokiten
- Coenzyme Q10 (Standard)
- (all-E)-2-(3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaenyl)-5,6-dimethoxy-3-methyl-2,5-cyclohe xadiene-1,4-dione;Bio-quinone Q10;CoQ10
- 206-147-9
- HY-N0111R
- FC20535
-
- MDL: MFCD00042919
- Inchi: 1S/C59O4/c1-44(2)24-15-25-45(3)26-16-27-46(4)28-17-29-47(5)30-18-31-48(6)32-19-33-49(7)34-20-35-50(8)36-21-37-51(9)38-22-39-52(10)40-23-41-53(11)42-43-55-54(12)56(60)58(62-13)59(63-14)57(55)61
- InChI Key: HFZDNFPTAQAFQQ-UHFFFAOYSA-N
- SMILES: [C]OC1C(=O)C([C])=C([C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C][C]=C([C][C]/[C]=C(\[C])/[C])[C])[C])[C])[C])[C])[C])[C])[C])[C])C(=O)C=1O[C] |^1:0,6,9,13,17,21,25,29,33,37,41,45,47,48,49,50,51,52,53,54,55,56,57,62,^4:8,11,12,15,16,19,20,23,24,27,28,31,32,35,36,39,40,43,44|
- BRN: 1900141
Computed Properties
- Exact Mass: 862.68400
- Monoisotopic Mass: 862.683911
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 63
- Rotatable Bond Count: 31
- Complexity: 1840
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 9
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 52.6
- Surface Charge: 0
- Tautomer Count: 57
- XLogP3: 19.4
- Molecular Weight: 863.3
Experimental Properties
- Color/Form: Coenzyme Q10 extracted from pig heart residue is a yellow or light orange yellow crystalline powder
- Density: 0.9145 (rough estimate)
- Melting Point: 47.0 to 52.0 deg-C
- Boiling Point: 869°C at 760 mmHg
- Flash Point: 324.5 °C
- Refractive Index: 1.4760 (estimate)
- Solubility: Soluble in chloroform.
- Stability/Shelf Life: Stable, but may be light or heat sensitive. Store in the dark at -20 C. Incompatible with strong oxidizing agents.
- PSA: 52.60000
- LogP: 17.85390
- Solubility: Soluble in chloroform, benzene, acetone, petroleum ether, diethyl ether, slightly soluble in ethanol, insoluble in water and methanol
- Vapor Pressure: 0.0 ± 3.3 mmHg at 25 ° C
- Merck: 9843
- Sensitiveness: Light Sensitive
coenzyme Q10 Security Information
- Signal Word:Warning
- Hazard Statement: H302-H315-H319-H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: S22; S24/25; S26
- FLUKA BRAND F CODES:8-10
- RTECS:DK3900000
-
Hazardous Material Identification:
- Risk Phrases:R36/37/38
- TSCA:Yes
- Storage Condition:4°C, protect from light
- Safety Term:S22;S24/25
coenzyme Q10 Customs Data
- HS CODE:2932999099
- Customs Data:
China Customs Code:
2932999099Overview:
2932999099. Other heterocyclic compounds containing only oxygen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
coenzyme Q10 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 07386-10MG |
coenzyme Q10 |
303-98-0 | 10mg |
¥1596.34 | 2024-12-26 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | PHR1929-500MG |
coenzyme Q10 |
303-98-0 | 500mg |
¥3691.01 | 2024-12-25 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 1705301-200MG |
coenzyme Q10 |
303-98-0 | 200mg |
¥4785.62 | 2025-01-16 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 1705312-25MG |
coenzyme Q10 |
303-98-0 | 25mg |
¥11142.25 | 2025-01-11 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | U0020000 |
coenzyme Q10 |
303-98-0 | European Pharmacopoeia (EP) Reference Standard | ¥2654.27 | 2022-02-23 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | U0020001 |
coenzyme Q10 |
303-98-0 | European Pharmacopoeia (EP) Reference Standard | ¥2654.27 | 2022-02-23 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-EV845-1g |
coenzyme Q10 |
303-98-0 | 98% | 1g |
¥74.0 | 2022-05-30 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | A-EV845-5g |
coenzyme Q10 |
303-98-0 | 98% | 5g |
¥234.0 | 2022-05-30 | |
| TI XI AI ( SHANG HAI ) HUA CHENG GONG YE FA ZHAN Co., Ltd. | C1971-1G |
Coenzyme Q10 |
303-98-0 | >98.0%(HPLC) | 1g |
¥790.00 | 2024-04-16 | |
| abcr | AB353351-5 g |
Coenzyme Q-10, 98%; . |
303-98-0 | 98% | 5 g |
€95.60 | 2023-07-19 |
coenzyme Q10 Suppliers
coenzyme Q10 Related Literature
-
Zhi Tang,Shangfu Li,Xinyuan Guan,Philippe Schmitt-Kopplin,Shuhai Lin,Zongwei Cai Analyst 2014 139 5600
-
Wei Ma,Yi-Tao Long Chem. Soc. Rev. 2014 43 30
-
Megan K. Dorris,Craig E. Lunte Anal. Methods 2011 3 161
-
Masataka Ohtani,Shunichi Fukuzumi Chem. Commun. 2009 4997
-
M. Katsouli,V. Giannou,C. Tzia Food Funct. 2020 11 8878
Additional information on coenzyme Q10
Coenzyme Q10 and 303-98-0: Chemical Structure and Biological Significance
Coenzyme Q10 (CoQ10), also known as ubiquinone, is a naturally occurring compound with the chemical formula C59H90O4 and CAS number 303-98-0. This lipid-soluble molecule plays a pivotal role in the mitochondrial electron transport chain, serving as a critical component for cellular energy production. Structurally, CoQ10 consists of a benzoquinone ring and a hydrophobic tail of 10 isoprenyl units, which allows it to function within the lipid bilayer of cell membranes. The CAS number 303-98-0 is often referenced in pharmaceutical and biochemical research to identify the compound's purity and regulatory status. Recent studies highlight its antioxidant properties, which help mitigate oxidative stress—a key factor in aging and chronic diseases. Researchers are increasingly focusing on CoQ10's potential in treating neurodegenerative disorders like Parkinson's disease, making 303-98-0 a hotspot for drug development.
Coenzyme Q10 (303-98-0) in Pharmacology and Therapeutic Applications
The pharmacological applications of Coenzyme Q10 (303-98-0) span cardiovascular health, metabolic disorders, and even skincare. Clinically, it is used as an adjunct therapy for heart failure due to its ability to improve endothelial function and reduce inflammation. A growing body of evidence suggests that supplementation with CoQ10 can lower blood pressure and improve symptoms in patients with statin-induced myopathy. The compound's role in mitochondrial dysfunction has also sparked interest in its use for diabetes management. With the rise of personalized medicine, researchers are exploring how genetic variations affect CoQ10 metabolism, tailoring dosages for optimal efficacy. The demand for high-purity 303-98-0 in nutraceuticals underscores its commercial and therapeutic value.
Coenzyme Q10 (303-98-0) Research Trends and Future Directions
Recent advancements in Coenzyme Q10 (303-98-0) research focus on enhancing bioavailability and targeted delivery systems. Nanoemulsions and liposomal formulations are being tested to overcome the compound's poor water solubility, a major limitation in oral administration. Another emerging trend is the synergy between CoQ10 and other antioxidants like vitamin E, which amplifies its neuroprotective effects. The biotech industry is also investigating microbial fermentation as a sustainable production method for 303-98-0, reducing reliance on chemical synthesis. With the global CoQ10 market projected to grow exponentially, driven by aging populations and rising health awareness, 303-98-0 remains a focal point for innovation in nutraceuticals and precision medicine.
Safety and Regulatory Status of Coenzyme Q10 (303-98-0)
The safety profile of Coenzyme Q10 (303-98-0) is well-documented, with the FDA granting it Generally Recognized as Safe (GRAS) status for dietary supplements. Clinical trials report minimal side effects, typically limited to mild gastrointestinal discomfort at high doses. However, regulatory agencies emphasize the importance of standardized testing to ensure the absence of contaminants in CoQ10 products. In the EU, the European Food Safety Authority (EFSA) has approved health claims related to its antioxidant properties. As counterfeit supplements proliferate, consumers are advised to verify the CAS number 303-98-0 to authenticate product quality. Ongoing post-market surveillance continues to reinforce its safety for long-term use.
Coenzyme Q10 (303-98-0) in Cosmeceuticals and Anti-Aging
The cosmetic industry has embraced Coenzyme Q10 (303-98-0) for its anti-aging and skin-repair benefits. Topical formulations containing CoQ10 are shown to reduce wrinkles by neutralizing free radicals and stimulating collagen production. Its small molecular weight enables deep dermal penetration, making it a staple in serums and creams. Studies also highlight its efficacy in protecting against UV-induced photodamage, a leading cause of premature aging. With consumers increasingly seeking evidence-backed ingredients, products listing 303-98-0 on their labels gain trust and market traction. The convergence of dermatology and nutraceuticals is expected to drive further innovation in this space.
303-98-0 (coenzyme Q10) Related Products
- 65162-42-7(2,3-Dimethoxy-5-propyl-1,4-benzochinon)
- 24663-35-2(Coenzyme Q11)
- 27696-12-4(2,5-Cyclohexadiene-1,4-dione,2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecaen-1-yl]-5,6-dimethoxy-3-methyl-,radical ion(1-))
- 303-95-7(Coenzyme Q7)
- 303-97-9(Coenzyme Q9)
- 55486-00-5(Decylubiquinone)
- 4370-61-0(2,5-Cyclohexadiene-1,4-dione,2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E)-3,7,11,15,19-pentamethyl-2,6,10,14,18-eicosapentaen-1-yl]-)
- 1173-76-8(2,5-Cyclohexadiene-1,4-dione,2,3-dimethoxy-5-methyl-6-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrien-1-yl]-)
- 2394-68-5(Coenzyme Q8)
- 25222-34-8(2,5-Cyclohexadiene-1,4-dione,2-(3,7,11,15,19,23,27-heptamethyl-2,6,10,14,18,22,26-octacosaheptadienyl)-5,6-dimethoxy-3-methyl-,(Z,E,E,E,E,E)- (9CI))